Guggenheim Upgrades Sage Therapeutics (SAGE) to Buy

November 2, 2021 11:24 AM EDT
Get Alerts SAGE Hot Sheet
Price: $32.30 --0%

Rating Summary:
    14 Buy, 12 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 3 | Down: 10 | New: 7
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Guggenheim analyst Yatin Suneja upgraded Sage Therapeutics (NASDAQ: SAGE) from Neutral to Buy with a price target of $55.00.

For an analyst ratings summary and ratings history on Sage Therapeutics click here. For more ratings news on Sage Therapeutics click here.

Shares of Sage Therapeutics closed at $42.37 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Guggenheim